These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8544238)

  • 41. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
    Antonić J; Rakar S
    Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US?
    Brown DL; Frates MC; Laing FC; DiSalvo DN; Doubilet PM; Benson CB; Waitzkin ED; Muto MG
    Radiology; 1994 Feb; 190(2):333-6. PubMed ID: 8284377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.
    Sengoku K; Satoh T; Saitoh S; Abe M; Ishikawa M
    Int J Gynaecol Obstet; 1994 Jul; 46(1):39-43. PubMed ID: 7805982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of thymidine phosphorylase concentration with ultrasound-derived indices of blood flow in ovarian masses.
    Hata K; Hata T; Collins WP
    Cancer; 1997 Sep; 80(6):1079-84. PubMed ID: 9305708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simple ultrasound-based rules for the diagnosis of ovarian cancer.
    Timmerman D; Testa AC; Bourne T; Ameye L; Jurkovic D; Van Holsbeke C; Paladini D; Van Calster B; Vergote I; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):681-90. PubMed ID: 18504770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging.
    Weiner Z; Thaler I; Beck D; Rottem S; Deutsch M; Brandes JM
    Obstet Gynecol; 1992 Feb; 79(2):159-62. PubMed ID: 1731278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of blood flow in adnexal tumors by using color Doppler imaging and pulsed spectral analysis.
    Takac I
    Ultrasound Med Biol; 1998 Oct; 24(8):1137-41. PubMed ID: 9833582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses?
    Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):215-25. PubMed ID: 17201017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. E-flow doppler indices for prediction of benign and malignant ovarian tumors.
    Tongsong T; Wanapirak C; Neeyalavira V; Khunamornpong S; Sukpan K
    Asian Pac J Cancer Prev; 2009; 10(1):139-42. PubMed ID: 19469642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models.
    Marret H; Ecochard R; Giraudeau B; Golfier F; Raudrant D; Lansac J
    Ultrasound Obstet Gynecol; 2002 Dec; 20(6):597-604. PubMed ID: 12493050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validity of colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
    Antonić J; Rakar S
    Eur J Gynaecol Oncol; 1996; 17(1):29-35. PubMed ID: 8750512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone.
    Buy JN; Ghossain MA; Hugol D; Hassen K; Sciot C; Truc JB; Poitout P; Vadrot D
    AJR Am J Roentgenol; 1996 Feb; 166(2):385-93. PubMed ID: 8553953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Doppler flow and arterial location in ovarian tumors.
    Itakura T; Kikkawa F; Kajiyama H; Mitsui T; Kawai M; Mizutani S
    Int J Gynaecol Obstet; 2003 Dec; 83(3):277-83. PubMed ID: 14643038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiating between benign and malignant adnexal lesions with contrast-enhanced transvaginal ultrasonography.
    Szymanski M; Socha MW; Kowalkowska ME; Zielińska IB; Eljaszewicz A; Szymanski W
    Int J Gynaecol Obstet; 2015 Nov; 131(2):147-51. PubMed ID: 26254725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transvaginal Doppler ultrasound with colour flow imaging in benign and malignant ovarian lesions.
    Sawicki W; Spiewankiewicz B; Cendrowski K; Stelmachów J
    Clin Exp Obstet Gynecol; 1995; 22(2):137-42. PubMed ID: 7781180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gray scale and color flow Doppler characterization of uterine tumors.
    Carter JR; Lau M; Saltzman AK; Hartenbach EM; Chen MD; Johnson PR; Fowler JM; Carlson JW; Carson LF; Twiggs LB
    J Ultrasound Med; 1994 Nov; 13(11):835-40. PubMed ID: 7837328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor].
    Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N
    Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ovarian tumors of low malignant potential: transvaginal Doppler ultrasound features.
    Hata K; Hata T; Manabe A; Kitao M
    Gynecol Oncol; 1992 Jun; 45(3):259-64. PubMed ID: 1612501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of histomorphology of ovarian masses with color Doppler sonography.
    Fleischer AC; Cullinan JA; Jones HW; Page DL
    Ultrasound Med Biol; 1996; 22(5):555-9. PubMed ID: 8865552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transvaginal color Doppler sonography in adnexal masses: which parameter performs best?
    Alcázar JL; Ruiz-Perez ML; Errasti T
    Ultrasound Obstet Gynecol; 1996 Aug; 8(2):114-9. PubMed ID: 8883314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.